Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
The Bioenergetic Health Index: a new concept in mitochondrial translational research.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
The health promotion work of the district nurse: interpreting its embeddedness.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
Cytomegalovirus and multiple sclerosis risk.
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Diffusion Tensor Analysis of Pediatric Multiple Sclerosis and Clinically Isolated Syndromes.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
Gray Matter Involvement in Radiologically Isolated Syndrome.
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
Robotic therapy: the tipping point.
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies.
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »